A composite tool for predicting gestational diabetes or hypertensive disorders of pregnancy: development and temporal validation.
An early-pregnancy risk score identifies women at high risk for gestational diabetes or preeclampsia, enabling timely prevention interventions.
This study develops and validates a composite prediction tool for GDM and HDP using accessible early-pregnancy cardiometabolic risk markers, achieving clinically relevant predictive accuracy. Early identification of at-risk pregnancies enables timely lifestyle and pharmacological intervention to reduce maternal-fetal cardiometabolic consequences.
What the study was
- Study design
- Prediction model development and validation study
- Population
- Pregnant women at risk for gestational diabetes or hypertensive complications
- Category
- Diagnostics
- Maturity
- Validated
- Journal
- Computers in biology and medicine
Why it surfaced
Validated composite prediction tool for GDM/HDP with near-term clinical implementation potential; addresses cardiometabolic complications affecting maternal-fetal outcomes in a large at-risk population.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.